However, at the same concentration, tubeimoside-1 attenuated CXCR4 expression in breast cancer, thus inhibiting CXCL12-induced cell invasion and metastasis; the anti-metastasis effect might offer cancer patients better chances at long-term survival (141). The gene discussed is CXCR4; the disease is breast cancer.